[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346588-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346588-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","plod2-promotes-proliferation-migration-and-invasion-of-colorectal-cancer-cells-via-pi3k-akt-gsk3-signaling-pathway","PLOD2 promotes proliferation, migration and invasion of colorectal cancer cells via PI3K-AKT-GSK3β signaling pathway","","Colorectal cancer progression depends strongly on the tumor microenvironment, and PLOD2 is highly expressed in many cancers through its role in collagen biosynthesis. This study shows significant PLOD2 upregulation in colorectal cancer, correlating with clinical stage, lymph node metastasis, and nerve invasion. Functional assays indicate PLOD2 overexpression enhances proliferation, migration, and invasion, while PLOD2 silencing reduces these phenotypes. PI3K-AKT pathway enrichment, co-immunoprecipitation, and inhibitor/agonist rescue experiments demonstrate that PLOD2 promotes tumor cell behaviors by activating PI3K-AKT-GSK3β signaling.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/plod2-promotes-proliferation-migration-and-invasion-of-colorectal-cancer-cells-via-pi3k-akt-gsk3-signaling-pathway/346588/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/plod2-promotes-proliferation-migration-and-invasion-of-colorectal-cancer-cells-via-pi3k-akt-gsk3-signaling-pathway/346588.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does PLOD2 play in colorectal cancer progression?","Question",{"text":63,"@type":64},"PLOD2 is upregulated in colorectal cancer and enhances proliferation, migration, and invasion, indicating it promotes malignant progression through the PI3K-AKT-GSK3β signaling axis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which clinical features correlate with higher PLOD2 levels in colorectal cancer?",{"text":68,"@type":64},"Higher PLOD2 expression is closely associated with clinical stage, lymph node metastasis, and nerve invasion.",{"name":70,"@type":61,"acceptedAnswer":71},"How do PI3K pathway experiments support the mechanism?",{"text":72,"@type":64},"Pathway analysis suggests PI3K-AKT signaling involvement; co-immunoprecipitation confirms PLOD2 interacts with PI3K; inhibitor LY294002 and agonist 740Y-P rescue/reverse PLOD2-mediated effects on colorectal cancer cell behaviors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346588,1790542079,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPLOD2 promotes proliferation, migration and invasion of colorectal cancer cells via PI3KAKT-GSK3β signaling pathway  \nHua Fang1,3, Jing Zheng1,3, Shutong Ren1,3, Danjing Chen1, Yunli Wu2􀀍 & Xian-E Peng1,2􀀍  \nColorectal cancer (CRC) progression critically depends on the tumor microenvironment. PLOD2, an enzyme involved in collagen biosynthesis, is highly expressed in many cancers. While it promotes CRC growth via the USP15–AKT/mTOR pathway, its role in enhancing tumor cell migration and invasion remains unclear. Our study identified a significant upregulation of PLOD2 in colorectal cancer. This upregulation was closely associated with clinical stage, lymph node metastasis, and nerve invasion in CRC. Functional assays, including CCK-8, colony formation, wound healing, and Transwell migration and invasion assays, showed that PLOD2 overexpression enhanced CRC cell proliferation, migration, and invasion, while PLOD2 silencing exerted the opposite effects. Kyoto Encyclopedia of Genes and Genomes pathway analysis suggested that PLOD2 may influence CRC progression via the PI3K-AKT signaling pathway. Co-immunoprecipitation assays demonstrated that PLOD2 was co-precipitated with PI3K, confirming their interaction. Additionally, rescue experiments showed that the PI3K inhibitor LY294002 and the agonist 740Y-P could reverse PLOD2-mediated effects on CRC cell proliferation, migration, and invasion. This study demonstrates that PLOD2 promotes the proliferation, migration, and invasion ofCRC cells by interacting with PI3K to activate the PI3K-AKTGSK3β signaling pathway.  \nKeywords PLOD2, Colorectal cancer, Malignant progression, Metastasis, PI3K-AKT-GSK3β  \nAbbreviations  \nCRC Colorectal cancer  \nPLOD2 Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 KEGG Kyoto encyclopedia of genes and genomes  \nECM Extracellular matrix  \nEMT Epithelial–mesenchymal transition  \nDEGs Differentially expressed genes GEO Gene expression omnibus GO Gene ontology  \nTCGA The cancer genome atlas IHC Immunohistochemistry CO-IP Co-immunoprecipitation  \nColorectal cancer (CRC) is one of the most common malignant tumors worldwide1. Due to low early detection rates, the majority of patients present are diagnosed advanced-stage disease at diagnosis, resulting in unfavorable prognosis and diminished survival outcomes2. Therefore, it is crucial to identify effective biomarkers for the early detection and prognosis of CRC. Tumor progression is co-determined by tumor cells and their microenvironment. The extracellular matrix (ECM) serves as a crucial component of tumor development. Asthe most abundant protein and primary constituent of the ECM, collagen exhibits dual roles in both normal and cancerous tissue homeostasis3,4. Collagen generates biochemical and biophysical signals through its interactions with tumor cells. These signals regulate cell migration, invasion, and proliferation, thereby contributing to tumor  \n1Department of Epidemiology and Health Statistics, Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, China. 2Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China. 3Hua Fang, Jing Zheng and Shutong Ren are authors contributed equally to this work. 􀀍 [email: wuyunli422@163.com](email: wuyunli422@163.com); [peng123456@fjmu.edu.cn](peng123456@fjmu.edu.cn)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nprogression5–7. This study revealed that procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2), a key enzyme mediating collagen synthesis and cross-linking, was significantly upregulated in CRC tissues.  \nRecent studies have further emphasized the clinical significance of identifying reliable biomarkers for CRC progression. Inflammation-and nutrition-based biomarkers have been shown to predict disease outcomes and reflect ","cbCaiqGwwzLAatys","https://ap.wps.com/l/cbCaiqGwwzLAatys","pdf",10385276,13,"English","# Background\n## Tumor microenvironment and ECM\n## Need for biomarkers in colorectal cancer\n# Methods and experiments\n## Functional assays\n## Pathway analysis\n## Protein interaction and rescue experiments\n# Results\n## PLOD2 expression and clinicopathologic correlations\n## Effects on proliferation, migration, and invasion\n## PI3K-AKT signaling mechanism\n# Conclusion","[{\"question\":\"What role does PLOD2 play in colorectal cancer progression?\",\"answer\":\"PLOD2 is upregulated in colorectal cancer and enhances proliferation, migration, and invasion, indicating it promotes malignant progression through the PI3K-AKT-GSK3β signaling axis.\"},{\"question\":\"Which clinical features correlate with higher PLOD2 levels in colorectal cancer?\",\"answer\":\"Higher PLOD2 expression is closely associated with clinical stage, lymph node metastasis, and nerve invasion.\"},{\"question\":\"How do PI3K pathway experiments support the mechanism?\",\"answer\":\"Pathway analysis suggests PI3K-AKT signaling involvement; co-immunoprecipitation confirms PLOD2 interacts with PI3K; inhibitor LY294002 and agonist 740Y-P rescue/reverse PLOD2-mediated effects on colorectal cancer cell behaviors.\"}]","PLOD2 promotes proliferation, migration and invasion of colorectal cancer cells via PI3K-AKT-GSK3β signaling pathway | PDF",1790062050,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e04cfadf726d5d670d8689ad84553929.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f37fa5bccd9b2700db62900571a11f06.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc7c0aa0c8167e90f8581ac0b497a15f.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13f4f837519ce45c1621973733a478f8.webp",980,1287]